Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kleiner

Showing results (261-270 of 2,627) with videos related to

Pageof 263
Sort By:
Immunopharmacology and Immunotoxicology|March 1, 1993
Naloxone modulates NK-cell activity of human peripheral blood lymphocytes like an opioid agonistI Martin-Kleiner, J Gabrilovac
Immunopharmacology and Immunotoxicology|February 1, 1996
Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assayI Martin-Kleiner, J Gabrilovac
Hepatology (Baltimore, Md.)|April 29, 2009
Liver biopsy findings in chronic hepatitis BHaresh Mani, David E Kleiner
Biorxiv : the Preprint Server for Biology|April 17, 2023
Oxaliplatin Inhibits RNA Polymerase I via DNA Damage Signaling Targeted to the NucleolusMisha Nechay, Ralph E Kleiner
Oncotarget|November 16, 2011
Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapyMelanie Hoch, Denise Hilfiker-Kleiner
Digestive Diseases and Sciences|March 22, 2012
Pathologic changes in ipilimumab-related hepatitis in patients with metastatic melanomaDavid E Kleiner, David Berman
Current Opinion in Chemical Biology|December 9, 2019
High-throughput approaches to profile RNA-protein interactionsMisha Nechay, Ralph E Kleiner
Clinics in Liver Disease|November 23, 2019
Liver Histology: Diagnostic and Prognostic FeaturesBillel Gasmi, David E Kleiner
Journal of Health Care Finance|August 6, 2005
Quality assurance in the health care industryKim Ann Guth, Brian Kleiner
International Journal of Breast Cancer|January 16, 2013
Effects of Auraptene on IGF-1 Stimulated Cell Cycle Progression in the Human Breast Cancer Cell Line, MCF-7Prasad Krishnan, Heather Kleiner-Hancock
Pageof 263

Showing results (261-270 of 2,627) with videos related to

Sort By:
Pageof 263
Immunopharmacology and Immunotoxicology|March 1, 1993
Naloxone modulates NK-cell activity of human peripheral blood lymphocytes like an opioid agonistI Martin-Kleiner, J Gabrilovac
Immunopharmacology and Immunotoxicology|February 1, 1996
Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assayI Martin-Kleiner, J Gabrilovac
Hepatology (Baltimore, Md.)|April 29, 2009
Liver biopsy findings in chronic hepatitis BHaresh Mani, David E Kleiner
Biorxiv : the Preprint Server for Biology|April 17, 2023
Oxaliplatin Inhibits RNA Polymerase I via DNA Damage Signaling Targeted to the NucleolusMisha Nechay, Ralph E Kleiner
Oncotarget|November 16, 2011
Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapyMelanie Hoch, Denise Hilfiker-Kleiner
Digestive Diseases and Sciences|March 22, 2012
Pathologic changes in ipilimumab-related hepatitis in patients with metastatic melanomaDavid E Kleiner, David Berman
Current Opinion in Chemical Biology|December 9, 2019
High-throughput approaches to profile RNA-protein interactionsMisha Nechay, Ralph E Kleiner
Clinics in Liver Disease|November 23, 2019
Liver Histology: Diagnostic and Prognostic FeaturesBillel Gasmi, David E Kleiner
Journal of Health Care Finance|August 6, 2005
Quality assurance in the health care industryKim Ann Guth, Brian Kleiner
International Journal of Breast Cancer|January 16, 2013
Effects of Auraptene on IGF-1 Stimulated Cell Cycle Progression in the Human Breast Cancer Cell Line, MCF-7Prasad Krishnan, Heather Kleiner-Hancock
Pageof 263